BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Cell>Point 

7120 E. Orchard Road

Englewood  Colorado  80111  U.S.A.
Phone: 303-689-9693 Fax:


SEARCH JOBS




Industry
Biotechnology






 Company News
Cell>Point Announces Encouraging Results From 99mTc-EC-G Phase 2a Trial in Evaluating Presence and Severity of Coronary Artery Disease 4/10/2013 12:09:29 PM
Cell>Point and HYUN IMC Expand License in South Korea to Include Hanmi Pharmaceutical, Co., Ltd for Cancer and Heart Disease Imaging 3/12/2013 9:35:26 AM
Cell>Point to Present at the 26th Indian Cooperative Oncology Network (ICON) Meeting in Bengaluru, India 3/20/2012 6:11:43 AM
Cell>Point Announces Agreement with FDA on Special Protocol Assessment for Phase 3 Trial of Technetium-99m-EC-G for Imaging Lung Cancer 3/13/2012 10:38:06 AM
Cell>Point Executes Asia Pacific License with HYUN IMC for Cancer and Heart Disease Diagnostic Imaging Agent, Technetium-99m EC-G 2/29/2012 6:53:34 AM
Cell>Point Executes Brazil License with Radiopharmacus for Cancer and Heart Disease Molecular Imaging Drug, EC-G 1/25/2012 6:50:02 AM
Cell>Point Presents Phase 2 Clinical Trial Results Comparing its 99mTc-EC-G SPECT Cancer Imaging Agent to FDG PET at Society of Nuclear Medicine Annual Meeting June 7, 2011 6/6/2011 10:34:08 AM
Cell>Point Completes Phase 2 of Cancer Diagnostic Phase 2/3 Trial 6/29/2010 8:17:08 AM
Cell>Point Completes Phase 2 of Cancer Diagnostic Phase 2/3 Trial 6/28/2010 1:58:28 PM
Cell>Point Submits Investigational New Drug Application for Phase 1b/2 Trial of 99mTc-EC-G in Assessing Coronary Artery Disease 6/22/2010 11:49:16 AM
12